Noradrenaline (Tartrate) Renaudin (Noradrenaline Tartrate)

Noradrenaline, the active ingredient in Noradrenaline (Tartrate) Renaudin, is a vasopressor presented as an injection for intravenous use. It is employed to raise blood pressure in acute hypotensive states such as septic shock, cardiac arrest, and other critical care situations where rapid circulatory support is required.

GNH USA supplies Noradrenaline (Tartrate) Renaudin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company follows global quality standards and provides cold‑chain logistics for this injectable product.

Noradrenaline is used as a potent vasopressor in critical care settings to manage severe hypotension and circulatory failure.

- Hypotension: restores vascular tone and raises systemic blood pressure in acute low‑pressure states. - Cardiac arrest: provides immediate vasoconstriction to support coronary perfusion during resuscitation efforts. - Septic shock: counteracts vasodilatory shock by increasing peripheral vascular resistance and improving organ perfusion.

Noradrenaline may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypertension: excessive rise in blood pressure. - Tachycardia: increased heart rate. - Arrhythmias: irregular cardiac rhythm. - Headache: pressure‑type head discomfort.

Serious or Rare Side Effects: - Myocardial ischemia: reduced heart muscle blood flow. - Severe hypertension: dangerously high arterial pressure. - Tissue necrosis at extravasation site: local tissue death if the drug leaks from the vein. - Cardiac arrest: loss of heart function. - Pulmonary edema: fluid accumulation in lungs.

When using Noradrenaline, clinicians should observe several safety measures to minimize risks.

- Cardiac monitoring: continuous ECG and arterial pressure tracking. - Dose titration: adjust infusion to achieve target mean arterial pressure. - Contraindications: avoid in patients with pheochromocytoma or uncorrected hypovolemia. - Caution in coronary artery disease: monitor for myocardial ischemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenaline can interact with other medications, influencing cardiovascular responses.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive pressor effect. - Beta‑blockers: may blunt expected tachycardia.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin, ACE inhibitors): may require higher Noradrenaline doses. - Calcium channel blockers: additive cardiovascular effects. - Diuretics: volume depletion can enhance hypotensive response.